Saul E. Rivkin, MD, Founder of the Marsha Rivkin Center for Ovarian Cancer, Medical Oncologist, Swedish Cancer Institute, Seattle, WA, discusses the future of testing for early stage ovarian cancer.
References and Resources
De Leeuw JR, van Vliet MJ, Ausems MG. Predictors of choosing life-long screening or prophylactic surgery in women at high and moderate risk for breast and ovarian cancer. Fam Cancer. 2008 Mar 14; (1):35-39.
Evans GR, Gaarenstroom KN, Stirling D, et al. Screening for Familial Ovarian Cancer: Poor survival of BRCA1/2 related cancers. J Med Genet. 2008 Apr 15;(2):101-19.
Freedman DM, Chang SC, Falk RT, Purdue MP, Huang WY, McCarty CA, Hollis BW, Graubard BI, Berg CD, Ziegler RG. Serum Levels of Vitamin D Metabolites and Breast Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Curr Oncol Rep. 2007 Nov;9(6):472-7.
Sponsored by The Doctor’s Channel